NCT00976118View on ClinicalTrials.gov

Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

February 28, 2009

Conditions
Alzheimer's Disease
Interventions
DRUG

masitinib (AB1010)

oral masitinib 3 or 6 mg/kg/day

DRUG

placebo

matching placebo to masitinib

Sponsors

Lead Sponsor

AB Science
All Listed Sponsors
lead

AB Science

INDUSTRY